Barbara J. Gitlitz

8.4k citations

118 papers · 4.5k indexed · 1 hit paper · h-index 37

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Oncology 74
- Cancer Immunotherapy and Biomarkers 27
- Peptidase Inhibition and Analysis 11
- Lung Cancer Research Studies 11
Pulmonary and Respiratory Medicine 69
- Lung Cancer Treatments and Mutations 43
- Renal cell carcinoma treatment 18

Co-authors: Robert A. Figlin (34 shared papers)Arie S. Belldegrun (28 shared papers)Allan J. Pantuck (14 shared papers)Amnon Zisman (14 shared papers)Jonathan Said (10 shared papers)Fredrick Dorey (8 shared papers)Jean B. deKernion (8 shared papers)Debby H. Chao (11 shared papers)
Journals: Journal of Clinical Oncology (30 papers)Journal of Thoracic Oncology (12 papers)The Journal of Urology (9 papers)Annals of Oncology (7 papers)Journal of Immunotherapy (6 papers)
Partner nations: United States Italy China

In The Last Decade

Barbara J. Gitlitz

115 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System 2001 · 542 citations

Peers

Countries citing papers authored by Barbara J. Gitlitz

Since Specialization

Citations

This map shows the geographic impact of Barbara J. Gitlitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Gitlitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Gitlitz more than expected).

Fields of papers citing papers by Barbara J. Gitlitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. Gitlitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Gitlitz. The network helps show where Barbara J. Gitlitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara J. Gitlitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara J. Gitlitz Line = papers co-authored together Barbara J. Gitlitz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System Journal of Clinical Oncology ·Amnon Zisman, Allan J. Pantuck, Fredrick Dorey, Jonathan Said, Oleg Shvarts, Deanna Quintana, Barbara J. Gitlitz, Jean B. deKernion, Robert A. Figlin, Arie S. Belldegrun Hit paper breakdown →	2001	542
2	Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Lecia V. Sequist, Benjamin Besse, Thomas J. Lynch, Vincent A. Miller, Kwok‐Kin Wong, Barbara J. Gitlitz, Keith D. Eaton, Charles Zacharchuk, Amy Freyman, Christine Powell, Revathi Ananthakrishnan, Susan Quinn, Jean‐Charles Soria	2010	357
3	Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Athanassios Argiris, Marianna Koczywas, Barbara J. Gitlitz, Sachdev Thomas, Igor Espinoza‐Delgado, Everett E. Vokes, David R. Gandara, Chandra P. Belani	2009	212
4	Renal Cell Carcinoma With Retroperitoneal Lymph Nodes: Role of Lymph Node Dissection The Journal of Urology ·Allan J. Pantuck, Amnon Zisman, Fredrick Dorey, Debby H. Chao, Ken‐ryu Han, Jonathan Said, Barbara J. Gitlitz, Robert A. Figlin, Arie S. Belldegrun	2003	193
5	Renal Cell Carcinoma With Tumor Thrombus Extension: Biology, Role of Nephrectomy and Response to Immunotherapy The Journal of Urology ·Amnon Zisman, JEFF A. WIEDER, Allan J. Pantuck, Debby H. Chao, Frederick J. Dorey, Jonathan Said, Barbara J. Gitlitz, JEAN B. de KERNION, Robert A. Figlin, Arie S. Belldegrun	2003	135
6	Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma Journal of Thoracic Oncology ·Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara	2009	133
7	Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study Clinical Cancer Research ·Leora Horn, Jeffrey R. Infante, Karen L. Reckamp, George R. Blumenschein, Ticiana Leal, Saiama N. Waqar, Barbara J. Gitlitz, Rachel E. Sanborn, Jennifer G. Whisenant, Liping Du, Joel W. Neal, Jon P. Gockerman, Gary Dukart, Kimberly Harrow, Chris Liang, James J. Gibbons, Allison Holzhausen, Christine M. Lovly, Heather A. Wakelee	2018	131
8	Renal cell carcinoma with retroperitoneal lymph nodes Cancer ·Allan J. Pantuck, Amnon Zisman, Frederich Dorey, Debby H. Chao, Ken‐ryu Han, Jonathan Said, Barbara J. Gitlitz, Arie S. Belldegrun, Robert A. Figlin	2003	128
9	Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor The Journal of Urology ·Robert A. Figlin, William Pierce, Randir Kaboo, C L Tso, Nancy P. Moldawer, Barbara J. Gitlitz, Jean B. deKernion, Arie S. Belldegrun	1997	126
10	Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma Thyroid ·Julie Ann Sosa, Rossella Elisei, Barbara Jarząb, Jai Balkissoon, S. Lu, Chandrasekhar Bal, Shanthi Marur, Ann W. Gramza, R. Ben Yosef, Barbara J. Gitlitz, Bryan R. Haugen, Frank G. Ondrey, Charles Lu, S. M. Karandikar, Fadlo R. Khuri, Lisa Licitra, Scot C. Remick	2013	116
11	Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. PubMed ·C L Tso, William H. McBride, Jianrong Sun, Bijal Patel, Ke‐Hung Tsui, Sun H. Paik, Barbara J. Gitlitz, R. R. Caliliw, Arndt van Ophoven, Lily Wu, Jean B. deKernion, Arie S. Belldegrun	2001	109
12	REEVALUATION OF THE 1997 TNM CLASSIFICATION FOR RENAL CELL CARCINOMA: T1 AND T2 CUTOFF POINT AT 4.5 RATHER THAN 7 CM. BETTER CORRELATES WITH CLINICAL OUTCOME The Journal of Urology ·Amnon Zisman, Allan J. Pantuck, Debby H. Chao, Fredrick Dorey, Jonathan Said, Barbara J. Gitlitz, Jean B. deKernion, Robert A. Figlin, Arie S. Belldegrun	2001	107
13	Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib Clinical Cancer Research ·Linda Mileshkin, Rodney J. Hicks, Brett Hughes, Paul Mitchell, Veena Charu, Barbara J. Gitlitz, David Macfarlane, Benjamin Solomon, Lukas C. Amler, Wei Yu, Andrea Pirzkall, Bernard M. Fine	2011	106
14	Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma Urology ·Ken‐ryu Han, Allan J. Pantuck, Matthew Bui, Oleg Shvarts, Danielo Garcia de Freitas, Amnon Zisman, Bradley C. Leibovich, Frederick J. Dorey, Barbara J. Gitlitz, Robert A. Figlin, Arie S. Belldegrun	2003	93
15	Mathematical Model to Predict Individual Survival for Patients With Renal Cell Carcinoma Journal of Clinical Oncology ·Amnon Zisman, Allan J. Pantuck, Fredrick Dorey, Debby H. Chao, Barbara J. Gitlitz, Nancy P. Moldawer, Dana Lazarovici, Jean B. deKernion, Robert A. Figlin, Arie S. Belldegrun	2002	89
16	COLLECTING DUCT RENAL CELL CARCINOMA: CLINICAL STUDY OF A RARE TUMOR The Journal of Urology ·Debby H. Chao, Amnon Zisman, Allan J. Pantuck, Barbara J. Gitlitz, Stephen J. Freedland, Jonathan Said, Robert A. Figlin, Arie S. Belldegrun	2002	82
17	A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma Journal of Immunotherapy ·Barbara J. Gitlitz, Arie S. Belldegrun, Amnon Zisman, Debby H. Chao, Allan J. Pantuck, Andreas Hinkel, Peter F.A. Mulders, Nancy P. Moldawer, Cho-Lea Tso, Robert A. Figlin	2003	73
18	HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib Journal of Thoracic Oncology ·Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Carolina Kawamura Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti	2016	69
19	Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors Clinical Cancer Research ·Adil Daud, Smitha Krishnamurthi, Mansoor N. Saleh, Barbara J. Gitlitz, Mitesh J. Borad, Philip J. Gold, Elena G. Chiorean, Gregory M. Springett, Richat Abbas, Shefali Agarwal, Nathalie Bardy‐Bouxin, Poe‐Hirr Hsyu, Eric Leip, Kathleen Turnbull, Charles Zacharchuk, Wells A. Messersmith	2011	68
20	Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Janessa Laskin, Garth Nicholas, Christopher Lee, Barbara J. Gitlitz, Mark Vincent, Yvon Cormier, Joe Stephenson, Yee Ung, Rachel E. Sanborn, Bryn Pressnail, F. Warren Nugent, John Nemunaitis, Martin Gleave, Nevin Murray, Desirée Hao	2011	68

About Barbara J. Gitlitz

Barbara J. Gitlitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Biotechnology, Cancer Research and Otorhinolaryngology, having authored 118 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (43 papers), Cancer Immunotherapy and Biomarkers (27 papers), Renal cell carcinoma treatment (18 papers), Bladder and Urothelial Cancer Treatments (13 papers), Immunotherapy and Immune Responses (11 papers), Peptidase Inhibition and Analysis (11 papers), Lung Cancer Research Studies (11 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Oncology (1.9k citations), Cancer Research (855 citations), Molecular Biology (2.2k citations) and Immunology (490 citations). Barbara J. Gitlitz has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Robert A. Figlin, Arie S. Belldegrun, Allan J. Pantuck, Amnon Zisman, Jonathan Said, Fredrick Dorey, Jean B. deKernion, Debby H. Chao, David R. Gandara and Oleg Shvarts. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, The Journal of Urology, Annals of Oncology and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact